← Back to All Filings

Colgate-Palmolive Chief People Officer Sally Massey Receives Annual Equity Grants

Low SignificanceSeptember 18, 2026 at 9:17:01 PM UTC

COLGATE PALMOLIVE CO

$CL4CIK: 0000021665

Subscribe to track CL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“Š Insider Grant: Colgate-Palmolive Co ($CL)

Insider: Sally Massey (Chief People Officer) Transaction Date: 2026-09-16 Filing Date: 2026-09-18

Details: • RSU Grant: 3,333 shares of Common Stock at $0.00 • Option Grant: 23,065 Stock Options with an exercise price of $87.02 (expiring 2036-09-16) • Direct Shares Owned After: 15,397 • Indirect 401(k) Holdings: 8,199 shares

Significance: Low (Standard annual incentive equity compensation; not an open-market transaction).

Comprehensive Analysis

Executive Summary

On September 18, 2026, Colgate-Palmolive Co ($CL) reported equity grant awards for Chief People Officer Sally Massey via SEC Form 4. The transactions, dated September 16, 2026, represent routine incentive compensation consisting of Restricted Stock Units (RSUs) and stock options.

Transaction Details

  • Restricted Stock Units: Sally Massey received 3,333 RSUs under the issuer's incentive compensation plan at an acquisition price of $0.00 per share. These units vest in three equal annual installments beginning on the first anniversary of the grant date.
  • Stock Options: Massey was also granted 23,065 stock options (Right to Buy) with an exercise price of $87.02 per share and an expiration date of September 16, 2036. The options vest in one-third annual increments starting September 16, 2027.

Ownership Structure

Following these transactions:

  • Direct Ownership: 15,397 common shares (including unvested RSUs).
  • Indirect Ownership: 8,199 shares held via the Issuer's 401(k) Plan Trustee.
  • Derivative Holdings: 23,065 options exercisable at $87.02.

Market & Trading Significance

This filing carries Low trading significance. It reflects standard corporate compensation rather than discretionary open-market buying or selling by the insider. While it aligns executive incentives with long-term shareholder value, it provides no directional signal regarding near-term market expectations.

Topics:#CL#ColgatePalmolive#InsiderTrading#SECForm4#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.